Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
73
1.510
 Why?
Head and Neck Neoplasms
14
2012
288
1.260
 Why?
Carcinoma, Squamous Cell
12
2011
332
0.860
 Why?
Neck
7
2018
97
0.700
 Why?
Vascular Malformations
3
2010
103
0.650
 Why?
Head
5
2018
70
0.620
 Why?
Patients
1
2018
51
0.570
 Why?
Terminal Care
1
2018
48
0.560
 Why?
Flow Cytometry
7
2024
404
0.560
 Why?
Hemangioma
3
2018
84
0.540
 Why?
Attitude to Health
1
2018
192
0.530
 Why?
Laryngectomy
3
2013
27
0.530
 Why?
Laryngeal Neoplasms
2
2007
45
0.500
 Why?
Quality of Life
3
2012
868
0.460
 Why?
Carcinoma, Merkel Cell
4
2016
41
0.450
 Why?
Laser Therapy
3
2011
76
0.450
 Why?
Laryngeal Diseases
1
2013
12
0.410
 Why?
Herpes Simplex
1
2013
23
0.400
 Why?
Parotid Diseases
1
2012
3
0.400
 Why?
Nuclear Proteins
6
2015
251
0.400
 Why?
Neuromuscular Agents
1
2012
8
0.400
 Why?
Botulinum Toxins, Type A
1
2012
14
0.400
 Why?
Leukoplakia, Oral
1
2011
6
0.380
 Why?
Aminolevulinic Acid
1
2011
8
0.380
 Why?
Lasers, Dye
1
2011
10
0.370
 Why?
Eating
1
2012
159
0.370
 Why?
Photosensitizing Agents
1
2011
19
0.370
 Why?
Photochemotherapy
1
2011
32
0.360
 Why?
Survivors
1
2012
118
0.360
 Why?
Photoacoustic Techniques
2
2024
24
0.360
 Why?
Female
30
2024
28105
0.350
 Why?
Neoplastic Cells, Circulating
4
2019
34
0.350
 Why?
Humans
49
2024
52336
0.350
 Why?
Middle Aged
21
2024
13014
0.340
 Why?
Male
30
2024
26696
0.330
 Why?
Cheek
1
2010
9
0.330
 Why?
Lip
1
2010
11
0.330
 Why?
Pain
1
2012
360
0.330
 Why?
Facial Neoplasms
1
2010
22
0.330
 Why?
Receptors, Progesterone
1
2009
66
0.320
 Why?
Adult
21
2024
14139
0.310
 Why?
Aged
16
2018
10109
0.310
 Why?
Lymphatic Vessels
1
2009
44
0.310
 Why?
Postoperative Complications
3
2012
1066
0.310
 Why?
Skin Neoplasms
4
2016
500
0.300
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1031
0.290
 Why?
Surgical Flaps
1
2009
110
0.290
 Why?
Recurrent Laryngeal Nerve
1
2007
12
0.290
 Why?
Neoplasms
1
2018
1305
0.290
 Why?
Laryngeal Nerves
1
2007
15
0.290
 Why?
Melanoma
2
2022
280
0.280
 Why?
Erythrocytes
2
2024
70
0.280
 Why?
Factor VII
1
2007
3
0.270
 Why?
Intracranial Arteriovenous Malformations
1
2007
32
0.270
 Why?
Dilatation
2
2017
27
0.260
 Why?
Malaria
2
2024
37
0.240
 Why?
Adolescent
11
2024
6692
0.230
 Why?
Gene Silencing
4
2009
119
0.230
 Why?
Disease Models, Animal
3
2016
1484
0.230
 Why?
Cell Proliferation
4
2016
1029
0.210
 Why?
Melanoma, Experimental
2
2016
34
0.210
 Why?
Retrospective Studies
10
2015
6578
0.200
 Why?
Immunohistochemistry
8
2014
985
0.200
 Why?
Treatment Outcome
7
2018
5407
0.200
 Why?
Muscarinic Agonists
1
2002
11
0.200
 Why?
Xerostomia
1
2002
4
0.190
 Why?
Promoter Regions, Genetic
7
2015
474
0.190
 Why?
Sjogren's Syndrome
1
2002
12
0.190
 Why?
Plasmodium yoelii
1
2022
12
0.190
 Why?
Endoscopy
2
2015
123
0.190
 Why?
Thiophenes
1
2002
38
0.190
 Why?
Nitric Oxide Synthase Type III
2
2013
82
0.190
 Why?
Quinuclidines
1
2002
40
0.190
 Why?
Transcription Factors
2
2015
574
0.180
 Why?
Embolization, Therapeutic
3
2011
88
0.180
 Why?
Veins
3
2010
74
0.180
 Why?
Azepines
3
2016
21
0.180
 Why?
Triazoles
3
2016
115
0.170
 Why?
Child
10
2012
7157
0.160
 Why?
Neoplasm Invasiveness
3
2010
278
0.160
 Why?
Child, Preschool
8
2012
4030
0.150
 Why?
Mast Cells
1
2018
55
0.150
 Why?
Mice
10
2022
5965
0.140
 Why?
Ki-67 Antigen
3
2013
58
0.140
 Why?
Combined Modality Therapy
4
2018
636
0.140
 Why?
Cricoid Cartilage
1
2017
11
0.140
 Why?
Estradiol
1
2018
215
0.140
 Why?
Trachea
1
2017
54
0.140
 Why?
Mice, Nude
5
2016
236
0.140
 Why?
Follow-Up Studies
3
2011
2268
0.130
 Why?
Lasers, Semiconductor
2
2022
7
0.130
 Why?
Biopsy
3
2015
604
0.130
 Why?
Infant
7
2018
3684
0.130
 Why?
Embolism
1
2016
18
0.130
 Why?
Neoplasm Staging
2
2010
770
0.130
 Why?
Benzoxazoles
1
2016
11
0.130
 Why?
Matrix Metalloproteinase 2
1
2016
58
0.130
 Why?
Matrix Metalloproteinase 9
1
2016
87
0.120
 Why?
Qualitative Research
1
2018
362
0.120
 Why?
Tracheotomy
1
2015
15
0.120
 Why?
TOR Serine-Threonine Kinases
1
2016
82
0.120
 Why?
Tracheal Stenosis
1
2015
13
0.120
 Why?
Laryngostenosis
1
2015
12
0.120
 Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
 Why?
Aged, 80 and over
6
2015
3391
0.120
 Why?
Larynx
2
2017
30
0.120
 Why?
Pyrimidines
1
2016
199
0.110
 Why?
Proto-Oncogene Proteins c-myc
1
2014
53
0.110
 Why?
Disease Progression
3
2014
870
0.110
 Why?
Fluorouracil
2
2004
59
0.110
 Why?
Carcinoma
2
2012
137
0.110
 Why?
Gene Expression Regulation, Neoplastic
3
2015
858
0.110
 Why?
DNA Methylation
5
2009
592
0.110
 Why?
Breast Neoplasms
2
2015
1206
0.110
 Why?
Plasmodium falciparum
2
2024
23
0.110
 Why?
Apoptosis
2
2016
1127
0.100
 Why?
Animals
10
2022
13523
0.100
 Why?
Mastication
1
2012
5
0.100
 Why?
Trismus
1
2012
2
0.100
 Why?
DNA, Neoplasm
2
2011
146
0.100
 Why?
Adaptor Proteins, Signal Transducing
3
2009
205
0.100
 Why?
Cisplatin
2
2004
285
0.100
 Why?
Radiotherapy, Adjuvant
1
2012
63
0.100
 Why?
Receptors, Cell Surface
1
2013
113
0.100
 Why?
Recurrence
2
2011
672
0.100
 Why?
Lymphangioma, Cystic
1
2011
10
0.090
 Why?
Endothelium, Lymphatic
1
2011
8
0.090
 Why?
Chemoradiotherapy
1
2012
50
0.090
 Why?
Syndrome
1
2012
247
0.090
 Why?
Cross-Sectional Studies
3
2024
1676
0.090
 Why?
Antigens, CD
1
2013
219
0.090
 Why?
Administration, Topical
1
2011
60
0.090
 Why?
Propranolol
1
2012
78
0.090
 Why?
Lymphatic Abnormalities
1
2011
20
0.090
 Why?
Immunoenzyme Techniques
4
2016
137
0.090
 Why?
Epigenesis, Genetic
1
2015
407
0.090
 Why?
Microtubule-Associated Proteins
1
2011
65
0.090
 Why?
Enteral Nutrition
1
2012
154
0.090
 Why?
Deglutition Disorders
1
2012
80
0.090
 Why?
Homeodomain Proteins
1
2011
81
0.090
 Why?
Brain Neoplasms
1
2014
290
0.090
 Why?
Diagnosis, Differential
2
2011
1044
0.090
 Why?
Tumor Suppressor Proteins
1
2011
132
0.090
 Why?
Weight Gain
1
2012
240
0.090
 Why?
Risk Assessment
1
2015
1323
0.090
 Why?
Epigenomics
1
2011
75
0.090
 Why?
Xenograft Model Antitumor Assays
3
2016
222
0.090
 Why?
Lip Neoplasms
1
2010
3
0.080
 Why?
Diagnostic Imaging
1
2011
174
0.080
 Why?
Neoplasm Proteins
2
2003
334
0.080
 Why?
Neoplastic Stem Cells
1
2011
93
0.080
 Why?
Hospitals, Teaching
1
2010
53
0.080
 Why?
Neoplasm Recurrence, Local
2
2019
643
0.080
 Why?
Lasers, Solid-State
1
2010
31
0.080
 Why?
Survival Rate
3
2011
940
0.080
 Why?
Microsatellite Instability
1
2009
21
0.080
 Why?
Medical Records
1
2010
86
0.080
 Why?
Neoadjuvant Therapy
1
2011
125
0.080
 Why?
Melanins
1
2009
19
0.080
 Why?
Vascular Surgical Procedures
1
2011
166
0.080
 Why?
Mouth
1
2010
33
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Carcinoma, Medullary
1
2009
12
0.080
 Why?
Young Adult
3
2024
4319
0.080
 Why?
Pilot Projects
1
2011
719
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Receptors, Estrogen
1
2009
132
0.080
 Why?
Immunotherapy
1
2011
244
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
24
0.080
 Why?
Port-Wine Stain
1
2008
14
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
137
0.080
 Why?
Blotting, Western
3
2016
596
0.070
 Why?
Dose-Response Relationship, Drug
1
2011
1377
0.070
 Why?
Vascular Endothelial Growth Factor A
1
2008
186
0.070
 Why?
Thyroid Neoplasms
1
2009
116
0.070
 Why?
Cytokines
1
2011
625
0.070
 Why?
Early Detection of Cancer
2
2022
183
0.070
 Why?
Tumor Cells, Cultured
3
2016
456
0.070
 Why?
Factor VIIa
1
2007
8
0.070
 Why?
Jaw Diseases
1
2007
6
0.070
 Why?
Practice Guidelines as Topic
1
2010
487
0.070
 Why?
Infant, Newborn
2
2011
2826
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Osteonecrosis
1
2007
35
0.070
 Why?
Postoperative Hemorrhage
1
2007
54
0.070
 Why?
Tongue
1
2007
40
0.070
 Why?
Bone Density Conservation Agents
1
2007
75
0.060
 Why?
Diphosphonates
1
2007
92
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Cell Line, Tumor
3
2015
1436
0.060
 Why?
Recombinant Proteins
1
2007
491
0.060
 Why?
Prospective Studies
1
2011
2428
0.060
 Why?
Skin
1
2008
418
0.060
 Why?
Mice, Inbred NOD
2
2016
92
0.060
 Why?
Cameroon
1
2024
2
0.060
 Why?
Hemeproteins
1
2024
4
0.060
 Why?
Mice, SCID
2
2016
182
0.060
 Why?
Parasitemia
1
2024
6
0.060
 Why?
Neoplasm Metastasis
2
2015
240
0.060
 Why?
Malaria, Falciparum
1
2024
21
0.060
 Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
 Why?
DNA Repair Enzymes
1
2004
43
0.060
 Why?
Ataxia Telangiectasia
1
2004
6
0.050
 Why?
Statistics, Nonparametric
1
2004
192
0.050
 Why?
ROC Curve
1
2024
251
0.050
 Why?
Polymerase Chain Reaction
4
2009
460
0.050
 Why?
Genes, p16
1
2003
9
0.050
 Why?
Lymph Node Excision
1
2004
133
0.050
 Why?
Radiotherapy
1
2004
129
0.050
 Why?
Magnetic Resonance Angiography
2
2018
67
0.050
 Why?
Proteoglycans
1
2003
87
0.050
 Why?
Magnetic Resonance Imaging
2
2007
1543
0.050
 Why?
Antigens, Nuclear
2
2013
24
0.050
 Why?
Transplantation, Heterologous
2
2013
79
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
583
0.050
 Why?
Sensitivity and Specificity
1
2024
879
0.050
 Why?
Longitudinal Studies
1
2024
741
0.050
 Why?
Membrane Glycoproteins
1
2003
244
0.050
 Why?
Double-Blind Method
1
2002
713
0.040
 Why?
Survival Analysis
3
2009
671
0.040
 Why?
Tryptases
1
2018
4
0.040
 Why?
Estrogen Receptor beta
1
2018
54
0.040
 Why?
Arkansas
1
2004
2028
0.040
 Why?
Estrogen Receptor alpha
1
2018
85
0.040
 Why?
Protein Transport
1
2018
183
0.040
 Why?
Ultrasonography, Doppler
1
2018
42
0.040
 Why?
Biopsy, Fine-Needle
2
2009
107
0.030
 Why?
Cadaver
1
2017
95
0.030
 Why?
Pressure
1
2017
103
0.030
 Why?
Molecular Imaging
1
2016
28
0.030
 Why?
Serum
1
2016
32
0.030
 Why?
Risk Factors
3
2015
3872
0.030
 Why?
Drug Synergism
1
2016
148
0.030
 Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
19
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
186
0.030
 Why?
Acetylation
1
2015
96
0.030
 Why?
Enhancer Elements, Genetic
1
2015
59
0.030
 Why?
Keratin-20
1
2014
7
0.030
 Why?
Mammography
1
2015
97
0.030
 Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
 Why?
Drug Therapy, Combination
1
2016
395
0.030
 Why?
Prognosis
3
2004
2094
0.030
 Why?
Chromatin
1
2015
141
0.030
 Why?
Cell Cycle Proteins
1
2015
173
0.030
 Why?
HEK293 Cells
1
2014
232
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
38
0.030
 Why?
Gene Expression Regulation
1
2018
1006
0.030
 Why?
Comorbidity
1
2015
624
0.030
 Why?
Down-Regulation
1
2014
347
0.030
 Why?
Protein Binding
1
2015
680
0.030
 Why?
Actins
1
2013
117
0.020
 Why?
RNA, Messenger
1
2016
1142
0.020
 Why?
Base Sequence
2
2004
648
0.020
 Why?
Lymphocele
1
2011
7
0.020
 Why?
Tissue Survival
1
2011
10
0.020
 Why?
Predictive Value of Tests
1
2014
943
0.020
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
46
0.020
 Why?
Tissue Culture Techniques
1
2011
43
0.020
 Why?
Cell Line
1
2014
1045
0.020
 Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
 Why?
Gluconates
1
2011
1
0.020
 Why?
Indomethacin
1
2011
35
0.020
 Why?
Graft Survival
1
2011
160
0.020
 Why?
Injections, Subcutaneous
1
2011
50
0.020
 Why?
Interleukin-2
1
2011
69
0.020
 Why?
Gene Expression Profiling
1
2016
1110
0.020
 Why?
Carrier Proteins
2
2003
326
0.020
 Why?
Time Factors
2
2007
2957
0.020
 Why?
Cyclophosphamide
1
2011
171
0.020
 Why?
Interleukin-1beta
1
2011
86
0.020
 Why?
Interferon-gamma
1
2011
179
0.020
 Why?
Drug Administration Schedule
1
2011
372
0.020
 Why?
Glottis
1
2010
34
0.020
 Why?
Disease-Free Survival
1
2011
460
0.020
 Why?
Sclerotherapy
1
2010
46
0.020
 Why?
Endothelial Cells
1
2011
283
0.020
 Why?
Calcitonin
1
2009
30
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2011
397
0.020
 Why?
Thyroidectomy
1
2009
61
0.020
 Why?
Paraffin Embedding
1
2008
52
0.020
 Why?
Mice, Transgenic
1
2009
563
0.020
 Why?
Signal Transduction
1
2014
1716
0.020
 Why?
Curettage
1
2007
13
0.020
 Why?
Dental Care
1
2007
11
0.020
 Why?
Mouth Floor
1
2007
5
0.020
 Why?
Polyvinyl Alcohol
1
2007
10
0.020
 Why?
Hyperbaric Oxygenation
1
2007
15
0.020
 Why?
Collateral Circulation
1
2007
38
0.020
 Why?
Pharyngeal Diseases
1
2007
12
0.020
 Why?
Current Procedural Terminology
1
2006
11
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Cutaneous Fistula
1
2007
14
0.020
 Why?
Neck Dissection
1
2007
29
0.020
 Why?
Angiography
1
2007
114
0.020
 Why?
Office Visits
1
2006
45
0.020
 Why?
Fistula
1
2007
27
0.020
 Why?
Salvage Therapy
1
2007
136
0.020
 Why?
Imidazoles
1
2007
124
0.020
 Why?
Genetic Predisposition to Disease
1
2009
528
0.020
 Why?
Adrenal Cortex Hormones
1
2007
114
0.020
 Why?
Preoperative Care
1
2007
172
0.020
 Why?
Ultrasonography
1
2006
424
0.010
 Why?
United States
1
2015
5182
0.010
 Why?
Guanine
1
2004
40
0.010
 Why?
DNA Adducts
1
2004
79
0.010
 Why?
Methylation
1
2004
126
0.010
 Why?
Syndecans
1
2003
37
0.010
 Why?
Syndecan-1
1
2003
73
0.010
 Why?
Base Pair Mismatch
1
2003
21
0.010
 Why?
Cell Count
1
2003
144
0.010
 Why?
Antineoplastic Agents
1
2011
1222
0.010
 Why?
DNA Repair
1
2003
195
0.010
 Why?
Molecular Sequence Data
1
2003
792
0.010
 Why?
Alcohol Drinking
1
2003
236
0.010
 Why?
Anti-Bacterial Agents
1
2007
801
0.010
 Why?
Smoking
1
2003
518
0.010
 Why?
Multiple Myeloma
1
2007
3049
0.010
 Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department